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A number of recent studies have indicated the potential of ultrasound contrast agent imaging at high ultrasound frequencies. How-
ever, the acoustic properties of microbubbles at frequencies above 10 MHz remain poorly understood at present. In this study we char-
acterize the high frequency attenuation properties of (1) BR14, (2) BR14 that has been mechanically ﬁltered (1 and 2 lm pore sizes) to
exclude larger bubbles, and (3) the micron to submicron agent BG2423. A narrowband pulse-echo substitution method is employed with
a series of four transducers covering the frequency range from 2 to 50 MHz. For BR14, attenuation decreases rapidly from 2 to 10 MHz
and then more gradually from 10 to 50 MHz. For 2 lm ﬁltration, the attenuation peaks between 10 and 15 MHz. For 1 lm ﬁltration,
attenuation continues to rise until 50 MHz. The agent BG2423 exhibits a diﬀuse attenuation peak in the range of 15–25 MHz and
remains high until 50 MHz. These results demonstrate a strong inﬂuence of bubble size on high frequency attenuation curves, with bub-
ble diameters of 1–2 lm and below having more pronounced acoustic activity at frequencies above 10 MHz.
 2006 Elsevier B.V. All rights reserved.
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There is increasing interest in the use of microbubble
contrast agents at frequencies in the 10–50 MHz range,
where applications are possible in ophthalmology, small
animal imaging, and cardiology. Several studies have inves-
tigated their use in ‘linear’ imaging mode using ultrasound
biomicroscopy [1] and intravascular ultrasound (IVUS)
systems [2,3]. More recent work has shown that it is also
feasible to perform subharmonic and second harmonic
imaging at high frequencies [4,5]. In these studies, both0041-624X/$ - see front matter  2006 Elsevier B.V. All rights reserved.
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E-mail address: d.goertz@erasmusmc.nl (D.E. Goertz).conventional commercial agents and experimental liposo-
mal preparations with micron to submicron mean diame-
ters have been employed.
The acoustic properties of microbubbles at high fre-
quencies are not well understood at present, particularly
with regards to knowledge of resonant bubble sizes and
nonlinear scattering mechanisms. A reasonable hypothesis
is that smaller bubbles are more active at high frequencies:
for example, the resonant diameter of a free bubble at
20 MHz is 0.65 lm. The application of current models
for lipid encapsulated microbubbles also predicts increased
acoustic activity in bubbles of diameters 1–2 lm and below
for frequencies above 10 MHz (e.g. [6]). However, these
models are not validated at high frequencies and shell
properties required as input parameters are unknown.
From an experimental perspective, it has been shown that
mechanical ﬁltration of BR14 (Bracco Research, Geneva)
e132 D.E. Goertz et al. / Ultrasonics 44 (2006) e131–e134using 1 and 2 lm pore sizes improves nonlinear scattering
at 20 and 30 MHz transmit frequencies [6]. Further, the
experimental micron to submicron lipid encapsulated agent
BG2423 (Bracco Research, Geneva) has been shown to
have substantial nonlinear activity (subharmonics and sec-
ond harmonics) for transmit frequencies of 20–40 MHz
[5,7].
While attenuation measurements have been widely
employed at lower frequencies (<10 MHz) to gain insight
into bubble resonant frequencies and shell properties [8–
10], very little work has been done at high ultrasound fre-
quencies (>10 MHz) [11]. In this study we investigate the
attenuation properties of lipid encapsulated contrast agents
in the frequency range from 2 to 50 MHz.
2. Methods
2.1. Measurement system overview
Attenuation measurements were made using the pulse-
echo substitution method, an approach described in detail
elsewhere [8]. A series of four commercially available trans-
ducers (Panametrics Inc., Waltham, MA) was used to
cover the range of 2–50 MHz (Table 1). Agent was situated
in a sample chamber located within the transducer beam,Table 1
Transducer models (Panametrics), characteristics, and frequency range
Transducer
and model
Focal
length
(mm)
Aperture
(mm)
Path
length in
chamber
Nom. center
frequency
(MHz)
Frequency
range (MHz)
1. V304 75 25 42 2.25 2–3.5
2. V311 75 13 42 10 3–14
3. V317 50 6 29 20 8–30
4. V377 51 6 29 30 25–50
Fig. 1. Photograph of one of the sample chambers (SC) indicating the transduc
a water tank.which entered the chamber through a mylar window and
was then reﬂected oﬀ a steel plate located at focus. Two
sample chambers were used, each one having two transduc-
ers (Fig. 1).
An overview of the hardware conﬁguration is shown in
Fig. 2. An arbitrary waveform generator (AWG 520 Tek-
tronix, Beaverton, OR) was used to create low amplitude
pulses, which were ampliﬁed with an RF power ampliﬁer
(2100 L, ENI, Rochester, NY for transducers 1 and 2;
LPI-10, ENI, Rochester, NY for transducers 3 and 4)
and sent to one of four transducers. On receive, signals
were ampliﬁed (AU-1189 or AU-1263, Miteq Inc., Haup-
page, NY), bandpass ﬁltered, and then digitized (DP310,
Acqiris, Geneva). A sequence of narrowband pulses was
employed (20 cycles up to 10 MHz; 40 cycles for 10–
50 MHz) to sweep the bandwidth of each transducer indi-
vidually. The inter-pulse spacing was 200 ms, with
sequences repeated at a rate of 8 min1. The use of narrow-
band pulses permitted the use of low transmit pressure lev-
els that were controlled across a wide frequency range, in
order to avoid potential pressure dependent attenuation
eﬀects [12] and thereby to enable comparison with linear-
ized bubble models. This approach also extended the eﬀec-
tive frequency range of each individual transducer, in termsers (T), and reﬂective steel plates (P). These components were immersed in
Fig. 2. Schematic overview of the hardware employed.
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achieved with a wideband pulse. The pressure level used
was 25 kPa, as measured with a 0.075 mm needle hydro-
phone (Precision Acoustics Ltd., Dorchester, UK) at focus
in a water tank.
2.2. Agent handling
The agents examined were (1) BR14; (2) BR14 with its
population modiﬁed by mechanical ﬁltering (1 and 2 lm
pores sizes) to isolate small bubbles; and (3) BG2423, all
experimental lipid encapsulated agents from Bracco
Research (Geneva). According to size information pro-
vided by the manufacturer, BR14 has a mean volume
weighted diameter of 6.8 lm and BG2423 is comprised
substantially of micron to submicron bubbles. Agent was
diluted in IsotoneTM to the ratios shown in Table 2. Filtra-
tion was performed by gravity feed of diluted agent
through a porous polycarbonate membrane (Poretics 1 or
2 lm, GE Osmonics Inc), as also described in [6,8]. Mea-
surements began 1 min after the agent was placed within
the sample chamber, with agent undergoing gentle mixingTable 2
Agent dilution ratios
Agent Dilution ratio
B14 1:2000
BR14 (2 lm ﬁlter) 1:300
BR14 (1 lm ﬁlter) 1:150
BG2423 1:700
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Fig. 3. Frequency dependent attenuation data (mean and standard deviations
ﬁltering, and (d) BG2423.with a magnetic stirrer. For a given sample, a total of eight
measurements at each frequency were then performed dur-
ing 1 min. A total of four independent sample measure-
ments were made for native BR14 and BG2423 (i.e.
averaging 32 values per frequency in total), and two sam-
ples for ﬁltered cases (i.e. averaging 16 values per frequency
in total). All experiments were performed at room
temperature.
3. Results and discussion
The attenuation results are shown in Fig. 3(a)–(d). For
native BR14 (Fig. 3(a)), attenuation decreased steeply from
2 to 10 MHz and more gradually from 10 to 50 MHz.
These results indicate that its acoustic activity is most pro-
nounced at lower diagnostic frequencies (<10 MHz), as
may be expected with a mean bubble size of 6.8 lm.
When BR14 is passed through a 2 lm ﬁlter, the attenu-
ation peak is shifted towards 10–15 MHz before leveling oﬀ
until 50 MHz (Fig. 3(b)). This result suggests that there are
bubbles below 2 lm in diameter present within BR14 that
have signiﬁcant acoustic activity above 10 MHz. When
BR14 is passed through a 1 lm ﬁlter the attenuation at
10 MHz is low, but continues to rise until 50 MHz
(Fig. 3(c)). This suggests that there are bubbles below
1 lm in diameter present within BR14 that have signiﬁcant
acoustic activity up to 50 MHz. These data are consistent
with the results of [6], which showed that high frequency
(20 and 30 MHz transmit) nonlinear scattering (subhar-
monic and second harmonic) from BR14 is improved with
1 and 2 lm ﬁltering. It should be noted however that whileb
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under ‘gentle’ gravity fed conditions, it is not known if
the ﬁltration process may have modiﬁed the shell proper-
ties of the agent.
Attenuation for BG2423 exhibits a diﬀuse peak in the
range of 15–25 MHz, and remains high until 50 MHz
(Fig. 3(d)). This agent has been found to have signiﬁcant
nonlinear activity at transmit frequencies from 20 to
40 MHz [5,7]. It is also notable that the form of the atten-
uation curve for this agent (comprised of micron to submi-
cron sized bubbles) is intermediate between 1 and 2 lm
ﬁltration results.
4. Conclusions
Frequency dependent attenuation has been measured in
the 2–50 MHz range for several lipid encapsulated bubble
populations. The results of this study demonstrate a strong
inﬂuence of bubble size on high frequency attenuation
curves, with bubbles below 1–2 lm in diameter exhibiting
more pronounced acoustic activity at frequencies above
10 MHz. This is consistent with the results of previous
studies examining nonlinear activity of small bubble popu-
lations at high frequencies. These results also support the
conclusion that agents with improved activity at high fre-
quencies can be obtained through either the manufacture
of small bubble agents or the modiﬁcation of existing
agents designed for use at lower frequencies. Future work
with attenuation measurements will entail analyzing the
data in combination with size distribution information to
gain insight into shell properties and the relationship
between bubble size and resonant frequencies above
10 MHz.
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